Revenue
2022
2023
2024
2025
BiomX Inc. (PHGE)
Price—Loading quote
Net income
2018
2019
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 · Dec 31 | 2019 · Jun 30 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — |
| Research & development | $21.3M | $24.7M | $16.7M | $16.2M | $22.7M | $19.4M | $13.5M | — | $9.1M |
| Operating expenses | $30.9M | $35.6M | $25.3M | $376,000 | — | — | — | $404,521 | $28,000 |
| Operating income | −$41.5M | −$44.5M | −$25.3M | −$27.2M | −$35.5M | −$30.3M | −$22.2M | −$404,521 | −$12.5M |
| EBITDA | −$38.5M | −$42.7M | −$24.5M | −$24.7M | −$32.9M | −$29.6M | −$21.9M | — | −$12.3M |
| Net income | −$36.2M | −$17.7M | −$26.2M | −$28.3M | −$36.2M | −$30.1M | −$20.6M | $347,407 | −$12.7M |
| Basic EPSper basic share | $22.19 | $25.37 | $5.10 | $0.95 | $1.39 | $1.30 | $3.66 | -$0.15 | $7.62 |
| Diluted EPSper diluted share | $22.19 | $58.31 | $5.10 | $0.95 | $1.39 | $1.30 | $3.66 | -$0.15 | $7.62 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) / Deerfield Private Design Fund V, L.P. / Deerfield Healthcare Innovations Fund II, L.P. / Deerfield Mgmt V, L.P. / Flynn James E / Deerfield Mgmt HIF, L.P. | 2.49M |
Cystic Fibrosis Foundation | 1.79M |
Solomon Jonathan Eitan | 126.75K |
Bassan Merav | 79.6K |
Wolfson Marina | 68.55K |
Oron Assaf | 25.8K |
Yeganeh Reuven | — |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 17, 2026Form 4 | Yeganeh ReuvenDirector,TenPercentOwner | SellCommon Stock, $0.0001 par value per share · indirect | 530.0K | $5.00 | $2.65M | 0 |
| Mar 16, 2026Form 4 | Yeganeh ReuvenDirector,TenPercentOwner | SellCommon Stock, $0.0001 par value per share · indirect | 450.0K | $5.00 | $2.25M | 0 |
| Mar 16, 2026Form 4 | Yeganeh ReuvenDirector,TenPercentOwner | SellCommon Stock Purchase Warrants · derivative · indirect | 1.70M | $4.76 | $8.09M | 0 |
| Mar 16, 2026Form 4 | Yeganeh ReuvenDirector,TenPercentOwner | SellCommon Stock Purchase Warrants · derivative · indirect | 2.00M | $5.24 | $10.48M | 1.70M |
| Mar 16, 2026Form 4 | Yeganeh ReuvenDirector,TenPercentOwner | SellCommon Stock Purchase Warrants · derivative · indirect | 1.30M | $5.00 | $6.50M | 2.00M |